medroxyprogesterone acetate has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, ML; Chlebowski, RT; Keiser, E; Larson, JC; Spaunhurst, KM; Stefanick, ML; Tang, JY; Thomas, F; Wactawski-Wende, J; Zeitouni, NC | 1 |
| Becher, R; Bojar, H; Höffken, K; Kloke, O; Scheulen, ME; Schmidt, CG; Wandl, UB | 1 |
| Mouridsen, HT; Pedersen, L; Rose, C | 1 |
1 trial(s) available for medroxyprogesterone acetate and Malignant Melanoma
| Article | Year |
|---|---|
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Topics: Aged; Confounding Factors, Epidemiologic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Melanoma; Menopause; Middle Aged; Odds Ratio; Proportional Hazards Models; Risk Assessment; Risk Factors; Skin Neoplasms; Women's Health | 2011 |
2 other study(ies) available for medroxyprogesterone acetate and Malignant Melanoma
| Article | Year |
|---|---|
Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
Topics: Antineoplastic Agents; Drug Evaluation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Melanoma | 1989 |
Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Female; Hormone Antagonists; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Melanoma; Middle Aged; Progestins; Tamoxifen | 1985 |